posted on 2018-05-17, 00:00authored byHaijun Cui, Binshuai Wang, Wenshuo Wang, Yuwei Hao, Chuanyong Liu, Kai Song, Shudong Zhang, Shutao Wang
Developing low-cost
and highly efficient nanobiochips are important
for liquid biopsies, real-time monitoring, and precision medicine.
By in situ growth of silica nanowires on a commercial frosted slide,
we develop a biochip for effective circulating tumor cells (CTCs)
detection after modifying epithelial cell adhesion molecule antibody
(anti-EpCAM). The biochip shows the specificity and high capture efficiency
of 85.4 ± 8.3% for prostate cancer cell line (PC-3). The microsized
frosted slides and silica nanowires allow enhanced efficiency in capture
EpCAM positive cells by synergistic topographic interactions. And
the capture efficiency of biochip increased with the increase of silica
nanowires length on frosted slide. The biochip shows that micro/nanocomposite
structures improve the capture efficiency of PC-3 more than 70% toward
plain slide. Furthermore, the nanobiochip has been successfully applied
to identify CTCs from whole blood specimens of prostate cancer patients.
Thus, this frosted slide-based biochip may provide a cheap and effective
way of clinical monitoring of CTCs.